XML 25 R13.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS
 6 Months Ended
Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS COMMITMENTS
Leases
Sangamo occupies approximately 87,700 square feet of office and research and development laboratory facilities in Brisbane, California, pursuant to a lease that expires in May 2029. Sangamo also occupies approximately 59,200 square feet of research and office space in Richmond, California, pursuant to leases that expire in August 2026. In addition, the Company leases approximately 25,600 square feet of office, and research and development space in Valbonne, France, subject to leases that expire beginning in June 2025 through January 2030.
Certain of these leases include renewal options at the election of the Company to renew or extend the lease for an additional five to ten years. These optional periods have not been considered in the determination of the ROU assets or lease liabilities associated with these leases as the Company did not consider it reasonably certain that it would exercise the options.
The Company performed evaluations of its contracts and determined each of its identified leases are operating leases. Components of operating leases were as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2021202020212020
Operating lease cost$2,697 $2,572 $5,385 $5,145 
Variable lease cost614 552 1,326 1,009 
Total$3,311 $3,124 $6,711 $6,154 
Variable lease expenses were not included in the measurement of the Company’s operating ROU assets and lease liabilities. This variable expense consists primarily of the Company’s proportionate share of operating expenses, property taxes and insurance and is classified as lease expense, due to the Company’s election to not separate lease and non-lease components.
Cash paid for amounts included in the measurement of operating lease liabilities for the six months ended June 30, 2021 and 2020, was $3.4 million and $3.1 million, respectively, and was included in net cash (used in) provided by operating activities in the Company’s Condensed Consolidated Statements of Cash Flows.
As of June 30, 2021, the maturities of the Company’s operating lease liabilities were as follows (in thousands):
Total
Six months ending December 31, 2021:$2,938 
20226,995 
20237,094 
20247,242 
20257,312 
Thereafter
20,044 
Total lease payments
51,625 
Less:
Imputed interest
(10,331)
Total
$41,294 
Reported as of June 30, 2021:
Short-term portion of lease liabilities (included in other accrued liabilities on the Condensed Consolidated Balance Sheets)$3,966 
Long-term portion of lease liabilities37,328 
Total
$41,294 
As of June 30, 2021, the weighted-average remaining lease term is 7.3 years and the weighted-average incremental borrowing rate used to determine the operating lease liability was 6.2% for the Company’s operating leases.
In January 2021, the Company entered into an amendment to an existing lease to acquire approximately 5,000 square feet of research and office space in Richmond, California. With this amendment, the existing lease expires in August 2026. Total lease payments over the life of this amended lease are approximately $0.9 million. Variable lease payments include the Company’s allocated share of costs incurred and expenditures made by the landlord in the operation and management of the building. On February 1, 2021, the lease commencement date, the Company recorded an operating lease right-of-use asset and a corresponding lease liability of $0.7 million.
In January 2021, the Company also entered into a new lease to acquire approximately 5,800 square feet of research and office space in Valbonne, France, which expires in January 2030. Total lease payments over the life of this amended lease are approximately $0.8 million. Variable lease payments include the Company’s allocated share of costs incurred and expenditures made by the landlord in the operation and management of the building. On January 29, 2021, the lease commencement date, the Company recorded an operating lease right-of-use asset and a corresponding lease liability of $0.6 million.
The Company does not have any financing leases.
Contractual Commitments
The following table sets forth the non-cancelable material contractual commitments under manufacturing-related supplier arrangements as of June 30, 2021 (in thousands):
Party
Total commitments
Expiry date
Brammer Bio MA - a Thermo Fisher Scientific Inc. subsidiary$4,579 December 2021
Lonza Netherlands, B.V.
9,513 December 2022
Total contractual commitments$14,092 
The Company also had $0.9 million of license obligations related to its intellectual property as of June 30, 2021.